Information Library
Hear From the Experts - Phase II/III
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by:
- Most Recent
- Title
-
Applications of Modeling and Simulation
May 27, 2010
Applications of Modeling and Simulation is discussed by Giridhar S. Tirucherai PhD, Director, Clinical PK-PD at Quintiles in the April issue of DIA Global Forum. -
Eric Siemers, MD
May 20, 2010
Eric Siemers, MD Medical Director, Alzheimer’s Disease Eli Lilly Eric Siemers, M.D. is Medical Director of the Alzheimer’s Disease Team at Eli Lilly -
Journal for Clinical Studies
May 12, 2010
In the March 2010 Journal for Clinical Studies, Dr. Erica Caveney and Dr. Rick Turner analyze the EMA Guidance on diabetes drugs and cardiovascular risk. -
Navigating Future Challenges in Alzheimer's Disease Trials
May 10, 2010
Learn more about this exciting program -
Mapping the Future in Oncology Drug Development
March 29, 2010
A world-renowned, multidisciplinary panel of experts to investigate challenges in, and propose strategies to enhance, oncology drug development. -
Journal for Clinical Studies
February 19, 2010
In the January 2010 Journal for Clinical Studies, Dr. Erica Caveney and Dr. Rick Turner analyze the FDA Guidance on diabetes drugs and cardiovascular risk. -
Podcast: Changing the Face of Cancer Research
August 31, 2009
Christopher Ung, Vice President, Strategic Business & Operations, Oncology, Quintiles, explains how advances in biomarker technology are ushering in a new era of cancer therapy development.
Page 1 of 1 (7 results)